Andreas Pahl
Directeur Général chez HEIDELBERG PHARMA AG
Postes actifs de Andreas Pahl
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| HEIDELBERG PHARMA AG | Directeur Général | 01/02/2024 | - |
| Directeur Technique/Scientifique/R&D | 01/01/2012 | 01/02/2024 | |
Heidelberg Pharma Research GmbH
 Heidelberg Pharma Research GmbH Miscellaneous Commercial ServicesCommercial Services Part of Heidelberg Pharma AG, Heidelberg Pharma Research GmbH is a German company that engages in researching biotechnology. The company is based in Ladenburg, Germany. The private company was founded in 2011. Andreas Pahl has been the CEO of the company since 2012. | Directeur Général | 01/02/2024 | - |
| Directeur Technique/Scientifique/R&D | 01/09/2012 | 01/02/2024 |
Historique de carrière de Andreas Pahl
Anciens postes connus de Andreas Pahl
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| Nycomed GmbH | Corporate Officer/Principal | - | - |
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Corporate Officer/Principal | - | - |
Emergence Therapeutics AG
 Emergence Therapeutics AG Pharmaceuticals: MajorHealth Technology Emergence Therapeutics AG is biopharmaceutical company. It develops novel antibody drug conjugate. The company was founded by Jack Elands and Xavier Preville and is headquartered in Duisburg, Germany. | Directeur/Membre du Conseil | - | - |
| Friedrich-Alexander University of Erlangen-Nuremberg | Corporate Officer/Principal | - | - |
| Technical University of Berlin | Corporate Officer/Principal | - | - |
Heidelberg Pharma AG /Old/
 Heidelberg Pharma AG /Old/ Miscellaneous Commercial ServicesCommercial Services Heidelberg Pharma AG provides drug development services. The firm also provides services for the pre-clinical development of new chemical or biological entities, which includes drug metabolism- and pharmacokinetic (DMPK) studies and pharmacology services in the field of cancer, inflammatory and autoimmune diseases. The company was founded in 1999 and is headquartered in Ladenburg, Germany. | Directeur Technique/Scientifique/R&D | 01/09/2012 | - |
Formation de Andreas Pahl
| Humboldt-Universität zu Berlin | Undergraduate Degree |
Statistiques
Internationale
| Allemagne | 9 |
| Japon | 2 |
Opérationnelle
| Corporate Officer/Principal | 4 |
| Chief Tech/Sci/R&D Officer | 3 |
| Chief Executive Officer | 2 |
Sectorielle
| Consumer Services | 4 |
| Health Technology | 4 |
| Commercial Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| HEIDELBERG PHARMA AG | Health Technology |
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Health Technology |
| Entreprise privées | 4 |
|---|---|
Heidelberg Pharma AG /Old/
Heidelberg Pharma AG /Old/ Miscellaneous Commercial ServicesCommercial Services Heidelberg Pharma AG provides drug development services. The firm also provides services for the pre-clinical development of new chemical or biological entities, which includes drug metabolism- and pharmacokinetic (DMPK) studies and pharmacology services in the field of cancer, inflammatory and autoimmune diseases. The company was founded in 1999 and is headquartered in Ladenburg, Germany. | Commercial Services |
Heidelberg Pharma Research GmbH
Heidelberg Pharma Research GmbH Miscellaneous Commercial ServicesCommercial Services Part of Heidelberg Pharma AG, Heidelberg Pharma Research GmbH is a German company that engages in researching biotechnology. The company is based in Ladenburg, Germany. The private company was founded in 2011. Andreas Pahl has been the CEO of the company since 2012. | Commercial Services |
Emergence Therapeutics AG
Emergence Therapeutics AG Pharmaceuticals: MajorHealth Technology Emergence Therapeutics AG is biopharmaceutical company. It develops novel antibody drug conjugate. The company was founded by Jack Elands and Xavier Preville and is headquartered in Duisburg, Germany. | Health Technology |
| Nycomed GmbH |
- Bourse
- Insiders
- Andreas Pahl
- Expérience
